Sexually Transmitted Diseases Testing and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Sexually Transmitted Diseases (STD) Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sexually Transmitted Diseases (STD) Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sexually Transmitted Diseases (STD) Testing Overall Market Size
2.1 Global Sexually Transmitted Diseases (STD) Testing Market Size: 2021 VS 2028
2.2 Global Sexually Transmitted Diseases (STD) Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Sexually Transmitted Diseases (STD) Testing Players in Global Market
3.2 Top Global Sexually Transmitted Diseases (STD) Testing Companies Ranked by Revenue
3.3 Global Sexually Transmitted Diseases (STD) Testing Revenue by Companies
3.4 Top 3 and Top 5 Sexually Transmitted Diseases (STD) Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sexually Transmitted Diseases (STD) Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sexually Transmitted Diseases (STD) Testing Players in Global Market
3.6.1 List of Global Tier 1 Sexually Transmitted Diseases (STD) Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Sexually Transmitted Diseases (STD) Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Sexually Transmitted Diseases (STD) Testing Market Size Markets, 2021 & 2028
4.1.2 Chlamydia
4.1.3 Syphilis
4.1.4 Gonorrhea
4.1.5 Herpes Simplex Virus
4.1.6 Human Papilloma Virus
4.1.7 Human Immunodeficiency Virus
4.1.8 Others
4.2 By Type - Global Sexually Transmitted Diseases (STD) Testing Revenue & Forecasts
4.2.1 By Type - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2017-2022
4.2.2 By Type - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2023-2028
4.2.3 By Type - Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sexually Transmitted Diseases (STD) Testing Market Size, 2021 & 2028
5.1.2 Laboratory Testing
5.1.3 Point of Care (POC) Testing
5.2 By Application - Global Sexually Transmitted Diseases (STD) Testing Revenue & Forecasts
5.2.1 By Application - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2017-2022
5.2.2 By Application - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2023-2028
5.2.3 By Application - Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Sexually Transmitted Diseases (STD) Testing Market Size, 2021 & 2028
6.2 By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue & Forecasts
6.2.1 By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2017-2022
6.2.2 By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue, 2023-2028
6.2.3 By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Sexually Transmitted Diseases (STD) Testing Revenue, 2017-2028
6.3.2 US Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.3.3 Canada Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.3.4 Mexico Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Sexually Transmitted Diseases (STD) Testing Revenue, 2017-2028
6.4.2 Germany Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.4.3 France Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.4.4 U.K. Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.4.5 Italy Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.4.6 Russia Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.4.7 Nordic Countries Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.4.8 Benelux Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Sexually Transmitted Diseases (STD) Testing Revenue, 2017-2028
6.5.2 China Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.5.3 Japan Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.5.4 South Korea Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.5.5 Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.5.6 India Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Sexually Transmitted Diseases (STD) Testing Revenue, 2017-2028
6.6.2 Brazil Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.6.3 Argentina Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue, 2017-2028
6.7.2 Turkey Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.7.3 Israel Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
6.7.5 UAE Sexually Transmitted Diseases (STD) Testing Market Size, 2017-2028
7 Players Profiles
7.1 ROCHE HOLDINGS
7.1.1 ROCHE HOLDINGS Corporate Summary
7.1.2 ROCHE HOLDINGS Business Overview
7.1.3 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Major Product Offerings
7.1.4 ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2017-2022)
7.1.5 ROCHE HOLDINGS Key News
7.2 BIOMERIEUX
7.2.1 BIOMERIEUX Corporate Summary
7.2.2 BIOMERIEUX Business Overview
7.2.3 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Major Product Offerings
7.2.4 BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2017-2022)
7.2.5 BIOMERIEUX Key News
7.3 HOLOGIC
7.3.1 HOLOGIC Corporate Summary
7.3.2 HOLOGIC Business Overview
7.3.3 HOLOGIC Sexually Transmitted Diseases (STD) Testing Major Product Offerings
7.3.4 HOLOGIC Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2017-2022)
7.3.5 HOLOGIC Key News
7.4 BECTON DICKINSON
7.4.1 BECTON DICKINSON Corporate Summary
7.4.2 BECTON DICKINSON Business Overview
7.4.3 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Major Product Offerings
7.4.4 BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2017-2022)
7.4.5 BECTON DICKINSON Key News
7.5 ORASURE
7.5.1 ORASURE Corporate Summary
7.5.2 ORASURE Business Overview
7.5.3 ORASURE Sexually Transmitted Diseases (STD) Testing Major Product Offerings
7.5.4 ORASURE Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2017-2022)
7.5.5 ORASURE Key News
7.6 DANAHER
7.6.1 DANAHER Corporate Summary
7.6.2 DANAHER Business Overview
7.6.3 DANAHER Sexually Transmitted Diseases (STD) Testing Major Product Offerings
7.6.4 DANAHER Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2017-2022)
7.6.5 DANAHER Key News
7.7 AFFYMETRIX
7.7.1 AFFYMETRIX Corporate Summary
7.7.2 AFFYMETRIX Business Overview
7.7.3 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Major Product Offerings
7.7.4 AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2017-2022)
7.7.5 AFFYMETRIX Key News
7.8 ABBOTT LABORATORIES
7.8.1 ABBOTT LABORATORIES Corporate Summary
7.8.2 ABBOTT LABORATORIES Business Overview
7.8.3 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Major Product Offerings
7.8.4 ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2017-2022)
7.8.5 ABBOTT LABORATORIES Key News
7.9 BIO-RAD LABORATORIES
7.9.1 BIO-RAD LABORATORIES Corporate Summary
7.9.2 BIO-RAD LABORATORIES Business Overview
7.9.3 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Major Product Offerings
7.9.4 BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2017-2022)
7.9.5 BIO-RAD LABORATORIES Key News
7.10 DIASORIN
7.10.1 DIASORIN Corporate Summary
7.10.2 DIASORIN Business Overview
7.10.3 DIASORIN Sexually Transmitted Diseases (STD) Testing Major Product Offerings
7.10.4 DIASORIN Sexually Transmitted Diseases (STD) Testing Revenue in Global Market (2017-2022)
7.10.5 DIASORIN Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Sexually Transmitted Diseases (STD) Testing Market Opportunities & Trends in Global Market
Table 2. Sexually Transmitted Diseases (STD) Testing Market Drivers in Global Market
Table 3. Sexually Transmitted Diseases (STD) Testing Market Restraints in Global Market
Table 4. Key Players of Sexually Transmitted Diseases (STD) Testing in Global Market
Table 5. Top Sexually Transmitted Diseases (STD) Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sexually Transmitted Diseases (STD) Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sexually Transmitted Diseases (STD) Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sexually Transmitted Diseases (STD) Testing Product Type
Table 9. List of Global Tier 1 Sexually Transmitted Diseases (STD) Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sexually Transmitted Diseases (STD) Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sexually Transmitted Diseases (STD) Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sexually Transmitted Diseases (STD) Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sexually Transmitted Diseases (STD) Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sexually Transmitted Diseases (STD) Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2023-2028
Table 30. ROCHE HOLDINGS Corporate Summary
Table 31. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Product Offerings
Table 32. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), (2017-2022)
Table 33. BIOMERIEUX Corporate Summary
Table 34. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Product Offerings
Table 35. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), (2017-2022)
Table 36. HOLOGIC Corporate Summary
Table 37. HOLOGIC Sexually Transmitted Diseases (STD) Testing Product Offerings
Table 38. HOLOGIC Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), (2017-2022)
Table 39. BECTON DICKINSON Corporate Summary
Table 40. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Product Offerings
Table 41. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), (2017-2022)
Table 42. ORASURE Corporate Summary
Table 43. ORASURE Sexually Transmitted Diseases (STD) Testing Product Offerings
Table 44. ORASURE Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), (2017-2022)
Table 45. DANAHER Corporate Summary
Table 46. DANAHER Sexually Transmitted Diseases (STD) Testing Product Offerings
Table 47. DANAHER Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), (2017-2022)
Table 48. AFFYMETRIX Corporate Summary
Table 49. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Product Offerings
Table 50. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), (2017-2022)
Table 51. ABBOTT LABORATORIES Corporate Summary
Table 52. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Product Offerings
Table 53. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), (2017-2022)
Table 54. BIO-RAD LABORATORIES Corporate Summary
Table 55. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Product Offerings
Table 56. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), (2017-2022)
Table 57. DIASORIN Corporate Summary
Table 58. DIASORIN Sexually Transmitted Diseases (STD) Testing Product Offerings
Table 59. DIASORIN Sexually Transmitted Diseases (STD) Testing Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Sexually Transmitted Diseases (STD) Testing Segment by Type in 2021
Figure 2. Sexually Transmitted Diseases (STD) Testing Segment by Application in 2021
Figure 3. Global Sexually Transmitted Diseases (STD) Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sexually Transmitted Diseases (STD) Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sexually Transmitted Diseases (STD) Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Testing Revenue in 2021
Figure 8. By Type - Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
Figure 12. US Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
Figure 16. Germany Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
Figure 24. China Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sexually Transmitted Diseases (STD) Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sexually Transmitted Diseases (STD) Testing Revenue, (US$, Mn), 2017-2028
Figure 37. ROCHE HOLDINGS Sexually Transmitted Diseases (STD) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BIOMERIEUX Sexually Transmitted Diseases (STD) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. HOLOGIC Sexually Transmitted Diseases (STD) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BECTON DICKINSON Sexually Transmitted Diseases (STD) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. ORASURE Sexually Transmitted Diseases (STD) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. DANAHER Sexually Transmitted Diseases (STD) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AFFYMETRIX Sexually Transmitted Diseases (STD) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. ABBOTT LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BIO-RAD LABORATORIES Sexually Transmitted Diseases (STD) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. DIASORIN Sexually Transmitted Diseases (STD) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)